Abstract
The cognitive status of patients with Parkinson’s disease (PD) who developed pathological gambling (PG) during dopamine replacement therapy has been poorly explored. We compared clinical and cognitive features of 21 consecutive PD patients with active PG (PD–PG) versus 42 PD controls of similar disease duration without any impulse control disorder. All patients underwent full neuropsychological testing to evaluate executive and other frontal lobe-related functions, attention, learning and memory, language, visuospatial abilities and neuropsychiatric status [using Geriatric Depression Scale (GDS) and Neuropsychiatric Inventory (NPI)] as well as the South Oaks Gambling Screen Scale (SOGS). PD–PG were younger (60.4 vs. 64.9, p = 0.01) and more frequently of male gender (85 vs. 57%, p = 0.02). The two groups did not differ in medication dosages and kind of dopamine agonist. PD–PG had higher MMSE (29.1 vs. 27.4, p = 0.02) and performed better at Rey Auditory Verbal learning Test (45.9 vs. 40.4, p = 0.04), verbal phonemic fluencies (38.7 vs. 31.8, p = 0.02), verbal semantic fluencies (44.9 vs. 37.4, p = 0.01) and attentive matrices (47.6 vs. 43.5, p = 0.05) while the remaining cognitive performances were comparable to controls. Moreover, based on the NPI, PD–PG had higher aggressiveness, irritability, disinhibition and eating disorders than controls. In conclusion the occurrence of PG in our cohort of patients with PD was associated with preserved executive functions.
Similar content being viewed by others
References
Weintraub D (2009) Dopamine and impulse control disorders in Parkinson’s disease. Ann Neurol 64(S2):S93–S100
Weintraub D, Koester J, Potenza M, Siderowf A, Stacy M, Whetteckey J, Wunderlich GR, Lang AE, FRCPC, for the DOMINION Study Group (2008) Dopaminergic therapy and impulse control disorders in Parkinson’s disease: top line results of a Cross-Sectional Study of over 3,000 patients. Mov Disord Suppl. LB4
Lu C, Bharmal A, Suchowersky O (2006) Gambling and Parkinson’s disease. Arch Neurol 63:298
Grosset KA, Macphee G, Pal G, Stewart D, Watt A, Davie J, Grosset DG (2006) Problematic gambling on dopamine agonists: not such a rarity. Mov Disord 21:2206–2208
American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders fourth edition: DSM-IV-TR. American Psychiatric Association, Washington, DC
Voon V, Fox SH (2007) Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 64(8):1089–1096
Potenza MN, Voon V, Weintraub D (2007) Drug insight: impulse control disorders and dopamine therapies in Parkinson’s disease. Nat Clin Pract Neurol 3(12):664–672
Isaias IU, Siri C, Cilia R, De Gaspari D, Pezzoli G, Antonini A (2008) The relationship between impulsivity and impulse control disorders in Parkinson’s disease. Mov Disord 23(3):411–415
Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, Fox S, Lang AE, Miyasaki J (2006) Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 67(7):1254–1257
Gallagher DA, O’Sullivan SS, Evans AH, Lees AJ, Schrag A (2007) Pathological gambling in Parkinson’s disease: risk factors and differences from dopamine dysregulation. An analysis of published case series. Mov Disord 22(12):1757–1763
Santangelo G, Vitale C, Trojano L, Verde F, Grossi D, Barone P (2009) Cognitive dysfunctions and pathological gambling in patients with Parkinson’s disease. Mov Disord 9 (Epub ahead of print)
Cilia R, Siri C, Marotta G, Isaias IU, De Gaspari D, Canesi M, Pezzoli G, Antonini A (2008) Functional abnormalities underlying pathological gambling in Parkinson disease. Arch Neurol 65(12):1604–1611
Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathologic study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184
Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson’s disease. Arch Neurol 56:33–39
Lesieur HR, Blume SB (1987) The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry 144(9):1184–1188
Battersby MW, Thomas LJ, Tolchard B, Esterman A (2002) The South Oaks Gambling Screen: a review with reference to Australian use. J Gambl Stud 18(3):257–271
Folstein MF, Folstein SE, McHugh PR (1975) ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
Heaton RK, Pendleton MG (1981) Use of neuropsychological tests to predict adult patients’ everyday functioning. J Consult Clin Psychol 49:807–821
Novelli P, Capitani L, Vallar G, Cappa S (1986) Test di fluenza verbale. Archivio di Psicologia, Neurologia e Psichiatria 47(4)
Basso A, Capitani E, Laiacona M (1987) Raven’s coloured progressive matrices: normative values on 305 adult normal controls. Funct Neurol 2(2):189–194
De Renzi E, Nichelli P (1975) Verbal and non verbal short term memory impairment following hemispheric damage. Cortex 11:33–41
Dubois B, Slaechevsky A, Litvan I, Pillon B (2000) The FAB: a frontal assessment battery at bedside. Neurology 55:1621–1626
Appollonio I, Leone M, Isella V, Piamarta F, Consoli T, Villa ML, Forapani E, Russo A, Nichelli P (2005) The frontal assessment battery (FAB): normative values in an Italian population sample. Neurol Sci 26:108–116
Wechsler D (1981) Wechsler Adult Intelligence scale. The Psychological Corporation, New York
Carlesimo GA, Caltagirone C, Gainotti G (1996) The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol 36(6):378–384
Spinnler H, Tognoni G (1987) Standardizzazione e taratura italiana di test neuropsicologici. Italian J of Neurol Sci 6(Suppl. 8):47–50
Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO (1983) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17:37–49
Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308–2314
Singh A, Kandimala G, Dewey RB, O’Suilleabhain P (2007) Risk factors for pathologic gambling and other compulsions among Parkinson’s disease patients taking dopamine agonists. J Clin Neurosci 14:1178–1181
Petry N, Stinson F, Grant B (2005) Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 66:564–574
Hoeft F, Watson CL, Kesler SR, Bettinger KE, Reiss AL (2008) Gender differences in the mesocorticolimbic system during computer game-play. J Psychiatr Res 42(4):253–258
Munro CA, McCaul ME, Wong DF, Oswald LM, Zhou Y, Brasic J, Kuwabara H, Kumar A, Alexander M, Ye W, Wand GS (2006) Sex differences in striatal dopamine release in healthy adults. Biol Psychiatry 59(10):966–974
Voon V, Thomsen T, Miyasaki JM, de Souza M, Shafro A, Fox SH, Duff-Canning S, Lang AE, Zurowski M (2007) Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol 64:212–216
Pagonabarraga J, Kulisevsky J, Llebaria G, García-Sánchez C, Pascual-Sedano B, Gironell A (2008) Parkinson’s disease-cognitive rating scale: a new cognitive scale specific for Parkinson’s disease. Mov Disord 23(7):998–1005
Caviness JN, Driver-Dunckley E, Connor DJ et al (2007) Defining mild cognitive impairment in Parkinson’s disease. Mov Disord 22(9):1272–1277
Kobayakawa M, Koyama S, Mimura M, Kawamura M (2008) Decision making in Parkinson’s disease: analysis of behavioral and physiological patterns in the Iowa gambling task. Mov Disord 23(4):547–552
Brand M, Labudda K, Kalbe E, Hilker R, Emmans D, Fuchs G, Kessler J, Markowitsch HJ (2004) Decision-making impairments in patients with Parkinson’s disease. Behav Neurol 15:77–85
Künig G, Leenders KL, Martin-Sölch C, Missimer J, Magyar S, Schultz W (2000) Reduced reward processing in the brains of Parkinsonian patients. Neuroreport 11(17):3681–3687
Fujii C, Harada S, Ohkoshi N, Hayashi A, Yoshizawa K (2000) Cross-cultural traits for personality of patients with Parkinson’s disease in Japan. Am J Med Genet 96(1):1–3
Dagher A, Robbins TW (2009) Personality, addiction, dopamine: insights from Parkinson’s disease. Neuron 61(4):502–510
Dodd ML, Klos KJ, Bower JH, Geda YE, Josephs KA, Ahlskog JE (2005) Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 62(9):1377–1381
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Siri, C., Cilia, R., De Gaspari, D. et al. Cognitive status of patients with Parkinson’s disease and pathological gambling. J Neurol 257, 247–252 (2010). https://doi.org/10.1007/s00415-009-5301-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-009-5301-5